nodes	percent_of_prediction	percent_of_DWPC	metapath
Dicyclomine—Oedema—Orlistat—type 2 diabetes mellitus	0.000746	0.00105	CcSEcCtD
Dicyclomine—Headache—Glipizide—type 2 diabetes mellitus	0.000745	0.00104	CcSEcCtD
Dicyclomine—Palpitations—Metformin—type 2 diabetes mellitus	0.000744	0.00104	CcSEcCtD
Dicyclomine—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000743	0.00104	CcSEcCtD
Dicyclomine—Shock—Valsartan—type 2 diabetes mellitus	0.000743	0.00104	CcSEcCtD
Dicyclomine—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.00074	0.00104	CcSEcCtD
Dicyclomine—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.00074	0.00104	CcSEcCtD
Dicyclomine—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000738	0.00103	CcSEcCtD
Dicyclomine—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	0.000737	0.00103	CcSEcCtD
Dicyclomine—Tension—Losartan—type 2 diabetes mellitus	0.000734	0.00103	CcSEcCtD
Dicyclomine—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000734	0.00103	CcSEcCtD
Dicyclomine—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000732	0.00103	CcSEcCtD
Dicyclomine—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000731	0.00103	CcSEcCtD
Dicyclomine—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000731	0.00103	CcSEcCtD
Dicyclomine—Agitation—Irbesartan—type 2 diabetes mellitus	0.00073	0.00102	CcSEcCtD
Dicyclomine—Somnolence—Gliclazide—type 2 diabetes mellitus	0.00073	0.00102	CcSEcCtD
Dicyclomine—Hypertension—Metformin—type 2 diabetes mellitus	0.000727	0.00102	CcSEcCtD
Dicyclomine—Urticaria—Glyburide—type 2 diabetes mellitus	0.000727	0.00102	CcSEcCtD
Dicyclomine—Nervousness—Losartan—type 2 diabetes mellitus	0.000726	0.00102	CcSEcCtD
Dicyclomine—Angioedema—Irbesartan—type 2 diabetes mellitus	0.000726	0.00102	CcSEcCtD
Dicyclomine—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000723	0.00101	CcSEcCtD
Dicyclomine—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000723	0.00101	CcSEcCtD
Dicyclomine—Anorexia—Valsartan—type 2 diabetes mellitus	0.000719	0.00101	CcSEcCtD
Dicyclomine—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000718	0.00101	CcSEcCtD
Dicyclomine—Malaise—Irbesartan—type 2 diabetes mellitus	0.000717	0.00101	CcSEcCtD
Dicyclomine—Headache—Pioglitazone—type 2 diabetes mellitus	0.000713	0.001	CcSEcCtD
Dicyclomine—Syncope—Irbesartan—type 2 diabetes mellitus	0.000713	0.001	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000709	0.000995	CcSEcCtD
Dicyclomine—Discomfort—Metformin—type 2 diabetes mellitus	0.000708	0.000994	CcSEcCtD
Dicyclomine—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000708	0.000993	CcSEcCtD
Dicyclomine—Nausea—Glipizide—type 2 diabetes mellitus	0.000706	0.00099	CcSEcCtD
Dicyclomine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000705	0.000989	CcSEcCtD
Dicyclomine—Vision blurred—Losartan—type 2 diabetes mellitus	0.000705	0.000989	CcSEcCtD
Dicyclomine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000703	0.000986	CcSEcCtD
Dicyclomine—Pain—Gliclazide—type 2 diabetes mellitus	0.000703	0.000985	CcSEcCtD
Dicyclomine—Constipation—Gliclazide—type 2 diabetes mellitus	0.000703	0.000985	CcSEcCtD
Dicyclomine—Rash—Glimepiride—type 2 diabetes mellitus	0.000699	0.000981	CcSEcCtD
Dicyclomine—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000699	0.00098	CcSEcCtD
Dicyclomine—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000699	0.00098	CcSEcCtD
Dicyclomine—Rash—Sitagliptin—type 2 diabetes mellitus	0.000697	0.000978	CcSEcCtD
Dicyclomine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000697	0.000977	CcSEcCtD
Dicyclomine—Headache—Glimepiride—type 2 diabetes mellitus	0.000695	0.000975	CcSEcCtD
Dicyclomine—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000694	0.000973	CcSEcCtD
Dicyclomine—Headache—Sitagliptin—type 2 diabetes mellitus	0.000693	0.000972	CcSEcCtD
Dicyclomine—Agitation—Losartan—type 2 diabetes mellitus	0.000687	0.000964	CcSEcCtD
Dicyclomine—Oedema—Metformin—type 2 diabetes mellitus	0.000687	0.000964	CcSEcCtD
Dicyclomine—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000686	0.000962	CcSEcCtD
Dicyclomine—Angioedema—Losartan—type 2 diabetes mellitus	0.000683	0.000959	CcSEcCtD
Dicyclomine—Insomnia—Valsartan—type 2 diabetes mellitus	0.000683	0.000958	CcSEcCtD
Dicyclomine—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000678	0.000951	CcSEcCtD
Dicyclomine—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000677	0.00095	CcSEcCtD
Dicyclomine—Shock—Metformin—type 2 diabetes mellitus	0.000676	0.000948	CcSEcCtD
Dicyclomine—Insomnia—Orlistat—type 2 diabetes mellitus	0.000675	0.000946	CcSEcCtD
Dicyclomine—Malaise—Losartan—type 2 diabetes mellitus	0.000674	0.000946	CcSEcCtD
Dicyclomine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000674	0.000945	CcSEcCtD
Dicyclomine—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000674	0.000945	CcSEcCtD
Dicyclomine—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000673	0.000944	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000672	0.000942	CcSEcCtD
Dicyclomine—Somnolence—Valsartan—type 2 diabetes mellitus	0.000671	0.000941	CcSEcCtD
Dicyclomine—Syncope—Losartan—type 2 diabetes mellitus	0.000671	0.000941	CcSEcCtD
Dicyclomine—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.00067	0.000939	CcSEcCtD
Dicyclomine—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000669	0.000938	CcSEcCtD
Dicyclomine—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000665	0.000933	CcSEcCtD
Dicyclomine—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000664	0.000932	CcSEcCtD
Dicyclomine—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000664	0.000931	CcSEcCtD
Dicyclomine—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000662	0.000928	CcSEcCtD
Dicyclomine—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000662	0.000928	CcSEcCtD
Dicyclomine—Palpitations—Losartan—type 2 diabetes mellitus	0.000661	0.000927	CcSEcCtD
Dicyclomine—Nausea—Glimepiride—type 2 diabetes mellitus	0.000659	0.000924	CcSEcCtD
Dicyclomine—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000657	0.000922	CcSEcCtD
Dicyclomine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000657	0.000921	CcSEcCtD
Dicyclomine—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000657	0.000921	CcSEcCtD
Dicyclomine—Asthenia—Glyburide—type 2 diabetes mellitus	0.000656	0.000921	CcSEcCtD
Dicyclomine—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000656	0.00092	CcSEcCtD
Dicyclomine—Anorexia—Metformin—type 2 diabetes mellitus	0.000655	0.000919	CcSEcCtD
Dicyclomine—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000653	0.000915	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000652	0.000914	CcSEcCtD
Dicyclomine—Fatigue—Valsartan—type 2 diabetes mellitus	0.000651	0.000913	CcSEcCtD
Dicyclomine—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000649	0.000911	CcSEcCtD
Dicyclomine—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000649	0.00091	CcSEcCtD
Dicyclomine—Oedema—Irbesartan—type 2 diabetes mellitus	0.000649	0.00091	CcSEcCtD
Dicyclomine—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000648	0.000909	CcSEcCtD
Dicyclomine—Pruritus—Glyburide—type 2 diabetes mellitus	0.000647	0.000908	CcSEcCtD
Dicyclomine—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000645	0.000905	CcSEcCtD
Dicyclomine—Constipation—Valsartan—type 2 diabetes mellitus	0.000645	0.000905	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000644	0.000903	CcSEcCtD
Dicyclomine—Fatigue—Orlistat—type 2 diabetes mellitus	0.000643	0.000902	CcSEcCtD
Dicyclomine—Erythema—Ramipril—type 2 diabetes mellitus	0.000641	0.0009	CcSEcCtD
Dicyclomine—Shock—Irbesartan—type 2 diabetes mellitus	0.000638	0.000895	CcSEcCtD
Dicyclomine—Pain—Orlistat—type 2 diabetes mellitus	0.000638	0.000895	CcSEcCtD
Dicyclomine—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000636	0.000893	CcSEcCtD
Dicyclomine—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000636	0.000892	CcSEcCtD
Dicyclomine—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000633	0.000888	CcSEcCtD
Dicyclomine—Rash—Bromocriptine—type 2 diabetes mellitus	0.000631	0.000885	CcSEcCtD
Dicyclomine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.00063	0.000884	CcSEcCtD
Dicyclomine—Tension—Ramipril—type 2 diabetes mellitus	0.000629	0.000883	CcSEcCtD
Dicyclomine—Discomfort—Losartan—type 2 diabetes mellitus	0.000629	0.000882	CcSEcCtD
Dicyclomine—Headache—Bromocriptine—type 2 diabetes mellitus	0.000627	0.000879	CcSEcCtD
Dicyclomine—Nervousness—Ramipril—type 2 diabetes mellitus	0.000623	0.000874	CcSEcCtD
Dicyclomine—Dry mouth—Losartan—type 2 diabetes mellitus	0.000623	0.000873	CcSEcCtD
Dicyclomine—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000618	0.000867	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000617	0.000866	CcSEcCtD
Dicyclomine—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000617	0.000866	CcSEcCtD
Dicyclomine—Confusional state—Losartan—type 2 diabetes mellitus	0.000615	0.000863	CcSEcCtD
Dicyclomine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000615	0.000862	CcSEcCtD
Dicyclomine—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000613	0.000859	CcSEcCtD
Dicyclomine—Somnolence—Metformin—type 2 diabetes mellitus	0.000611	0.000857	CcSEcCtD
Dicyclomine—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.00061	0.000856	CcSEcCtD
Dicyclomine—Oedema—Losartan—type 2 diabetes mellitus	0.00061	0.000856	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.00061	0.000855	CcSEcCtD
Dicyclomine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000605	0.000849	CcSEcCtD
Dicyclomine—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000605	0.000849	CcSEcCtD
Dicyclomine—Shock—Losartan—type 2 diabetes mellitus	0.000601	0.000842	CcSEcCtD
Dicyclomine—Urticaria—Valsartan—type 2 diabetes mellitus	0.0006	0.000841	CcSEcCtD
Dicyclomine—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000599	0.00084	CcSEcCtD
Dicyclomine—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000597	0.000838	CcSEcCtD
Dicyclomine—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000597	0.000837	CcSEcCtD
Dicyclomine—Tachycardia—Losartan—type 2 diabetes mellitus	0.000596	0.000836	CcSEcCtD
Dicyclomine—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.000595	0.000835	CcSEcCtD
Dicyclomine—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000594	0.000834	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000593	0.000832	CcSEcCtD
Dicyclomine—Fatigue—Metformin—type 2 diabetes mellitus	0.000593	0.000831	CcSEcCtD
Dicyclomine—Urticaria—Orlistat—type 2 diabetes mellitus	0.000592	0.000831	CcSEcCtD
Dicyclomine—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.00059	0.000827	CcSEcCtD
Dicyclomine—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000589	0.000827	CcSEcCtD
Dicyclomine—Agitation—Ramipril—type 2 diabetes mellitus	0.000589	0.000827	CcSEcCtD
Dicyclomine—Constipation—Metformin—type 2 diabetes mellitus	0.000588	0.000824	CcSEcCtD
Dicyclomine—Angioedema—Ramipril—type 2 diabetes mellitus	0.000586	0.000822	CcSEcCtD
Dicyclomine—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000582	0.000817	CcSEcCtD
Dicyclomine—Anorexia—Losartan—type 2 diabetes mellitus	0.000582	0.000816	CcSEcCtD
Dicyclomine—Vomiting—Glyburide—type 2 diabetes mellitus	0.000582	0.000816	CcSEcCtD
Dicyclomine—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000581	0.000815	CcSEcCtD
Dicyclomine—Malaise—Ramipril—type 2 diabetes mellitus	0.000578	0.000811	CcSEcCtD
Dicyclomine—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000578	0.000811	CcSEcCtD
Dicyclomine—Rash—Glyburide—type 2 diabetes mellitus	0.000577	0.000809	CcSEcCtD
Dicyclomine—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000577	0.000809	CcSEcCtD
Dicyclomine—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000576	0.000808	CcSEcCtD
Dicyclomine—Syncope—Ramipril—type 2 diabetes mellitus	0.000575	0.000807	CcSEcCtD
Dicyclomine—Headache—Glyburide—type 2 diabetes mellitus	0.000573	0.000804	CcSEcCtD
Dicyclomine—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000571	0.000801	CcSEcCtD
Dicyclomine—Palpitations—Ramipril—type 2 diabetes mellitus	0.000567	0.000795	CcSEcCtD
Dicyclomine—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000566	0.000794	CcSEcCtD
Dicyclomine—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000564	0.000791	CcSEcCtD
Dicyclomine—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000564	0.000791	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000562	0.000788	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.00056	0.000785	CcSEcCtD
Dicyclomine—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000559	0.000784	CcSEcCtD
Dicyclomine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000556	0.00078	CcSEcCtD
Dicyclomine—Pain—Irbesartan—type 2 diabetes mellitus	0.000555	0.000778	CcSEcCtD
Dicyclomine—Constipation—Irbesartan—type 2 diabetes mellitus	0.000555	0.000778	CcSEcCtD
Dicyclomine—Insomnia—Losartan—type 2 diabetes mellitus	0.000552	0.000774	CcSEcCtD
Dicyclomine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000549	0.000771	CcSEcCtD
Dicyclomine—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000548	0.000769	CcSEcCtD
Dicyclomine—Urticaria—Metformin—type 2 diabetes mellitus	0.000546	0.000766	CcSEcCtD
Dicyclomine—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000544	0.000763	CcSEcCtD
Dicyclomine—Nausea—Glyburide—type 2 diabetes mellitus	0.000543	0.000762	CcSEcCtD
Dicyclomine—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000543	0.000762	CcSEcCtD
Dicyclomine—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000543	0.000762	CcSEcCtD
Dicyclomine—Somnolence—Losartan—type 2 diabetes mellitus	0.000543	0.000761	CcSEcCtD
Dicyclomine—Asthenia—Valsartan—type 2 diabetes mellitus	0.000542	0.00076	CcSEcCtD
Dicyclomine—Discomfort—Ramipril—type 2 diabetes mellitus	0.000539	0.000757	CcSEcCtD
Dicyclomine—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000537	0.000754	CcSEcCtD
Dicyclomine—Asthenia—Orlistat—type 2 diabetes mellitus	0.000535	0.000751	CcSEcCtD
Dicyclomine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000535	0.00075	CcSEcCtD
Dicyclomine—Pruritus—Valsartan—type 2 diabetes mellitus	0.000534	0.000749	CcSEcCtD
Dicyclomine—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000534	0.000749	CcSEcCtD
Dicyclomine—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000531	0.000744	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.00053	0.000744	CcSEcCtD
Dicyclomine—Confusional state—Ramipril—type 2 diabetes mellitus	0.000528	0.00074	CcSEcCtD
Dicyclomine—Pruritus—Orlistat—type 2 diabetes mellitus	0.000528	0.00074	CcSEcCtD
Dicyclomine—Fatigue—Losartan—type 2 diabetes mellitus	0.000526	0.000738	CcSEcCtD
Dicyclomine—Oedema—Ramipril—type 2 diabetes mellitus	0.000523	0.000734	CcSEcCtD
Dicyclomine—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000523	0.000734	CcSEcCtD
Dicyclomine—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000522	0.000733	CcSEcCtD
Dicyclomine—Pain—Losartan—type 2 diabetes mellitus	0.000522	0.000732	CcSEcCtD
Dicyclomine—Constipation—Losartan—type 2 diabetes mellitus	0.000522	0.000732	CcSEcCtD
Dicyclomine—Rash—Gliclazide—type 2 diabetes mellitus	0.000518	0.000727	CcSEcCtD
Dicyclomine—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000517	0.000726	CcSEcCtD
Dicyclomine—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000515	0.000723	CcSEcCtD
Dicyclomine—Shock—Ramipril—type 2 diabetes mellitus	0.000515	0.000722	CcSEcCtD
Dicyclomine—Headache—Gliclazide—type 2 diabetes mellitus	0.000515	0.000722	CcSEcCtD
Dicyclomine—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000513	0.00072	CcSEcCtD
Dicyclomine—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000513	0.000719	CcSEcCtD
Dicyclomine—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000511	0.000717	CcSEcCtD
Dicyclomine—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000503	0.000706	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000499	0.0007	CcSEcCtD
Dicyclomine—Dizziness—Valsartan—type 2 diabetes mellitus	0.000499	0.0007	CcSEcCtD
Dicyclomine—Anorexia—Ramipril—type 2 diabetes mellitus	0.000499	0.0007	CcSEcCtD
Dicyclomine—Dizziness—Orlistat—type 2 diabetes mellitus	0.000493	0.000692	CcSEcCtD
Dicyclomine—Asthenia—Metformin—type 2 diabetes mellitus	0.000493	0.000692	CcSEcCtD
Dicyclomine—Nausea—Gliclazide—type 2 diabetes mellitus	0.000488	0.000684	CcSEcCtD
Dicyclomine—Pruritus—Metformin—type 2 diabetes mellitus	0.000486	0.000682	CcSEcCtD
Dicyclomine—Urticaria—Losartan—type 2 diabetes mellitus	0.000485	0.00068	CcSEcCtD
Dicyclomine—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000483	0.000677	CcSEcCtD
Dicyclomine—Vomiting—Valsartan—type 2 diabetes mellitus	0.00048	0.000673	CcSEcCtD
Dicyclomine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000478	0.00067	CcSEcCtD
Dicyclomine—Rash—Valsartan—type 2 diabetes mellitus	0.000476	0.000668	CcSEcCtD
Dicyclomine—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000475	0.000667	CcSEcCtD
Dicyclomine—Vomiting—Orlistat—type 2 diabetes mellitus	0.000474	0.000665	CcSEcCtD
Dicyclomine—Insomnia—Ramipril—type 2 diabetes mellitus	0.000473	0.000664	CcSEcCtD
Dicyclomine—Headache—Valsartan—type 2 diabetes mellitus	0.000473	0.000663	CcSEcCtD
Dicyclomine—Rash—Orlistat—type 2 diabetes mellitus	0.00047	0.00066	CcSEcCtD
Dicyclomine—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.00047	0.000659	CcSEcCtD
Dicyclomine—Dermatitis—Orlistat—type 2 diabetes mellitus	0.00047	0.000659	CcSEcCtD
Dicyclomine—Headache—Orlistat—type 2 diabetes mellitus	0.000467	0.000655	CcSEcCtD
Dicyclomine—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000467	0.000655	CcSEcCtD
Dicyclomine—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000465	0.000653	CcSEcCtD
Dicyclomine—Somnolence—Ramipril—type 2 diabetes mellitus	0.000465	0.000653	CcSEcCtD
Dicyclomine—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000461	0.000646	CcSEcCtD
Dicyclomine—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000459	0.000644	CcSEcCtD
Dicyclomine—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000455	0.000638	CcSEcCtD
Dicyclomine—Dizziness—Metformin—type 2 diabetes mellitus	0.000455	0.000638	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000452	0.000634	CcSEcCtD
Dicyclomine—Fatigue—Ramipril—type 2 diabetes mellitus	0.000451	0.000633	CcSEcCtD
Dicyclomine—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.00045	0.000631	CcSEcCtD
Dicyclomine—Nausea—Valsartan—type 2 diabetes mellitus	0.000448	0.000629	CcSEcCtD
Dicyclomine—Constipation—Ramipril—type 2 diabetes mellitus	0.000448	0.000628	CcSEcCtD
Dicyclomine—Nausea—Orlistat—type 2 diabetes mellitus	0.000443	0.000621	CcSEcCtD
Dicyclomine—Asthenia—Losartan—type 2 diabetes mellitus	0.000438	0.000614	CcSEcCtD
Dicyclomine—Vomiting—Metformin—type 2 diabetes mellitus	0.000437	0.000613	CcSEcCtD
Dicyclomine—Rash—Metformin—type 2 diabetes mellitus	0.000433	0.000608	CcSEcCtD
Dicyclomine—Dermatitis—Metformin—type 2 diabetes mellitus	0.000433	0.000607	CcSEcCtD
Dicyclomine—Pruritus—Losartan—type 2 diabetes mellitus	0.000432	0.000606	CcSEcCtD
Dicyclomine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000431	0.000605	CcSEcCtD
Dicyclomine—Headache—Metformin—type 2 diabetes mellitus	0.000431	0.000604	CcSEcCtD
Dicyclomine—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000429	0.000602	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000428	0.0006	CcSEcCtD
Dicyclomine—Urticaria—Ramipril—type 2 diabetes mellitus	0.000416	0.000583	CcSEcCtD
Dicyclomine—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000414	0.00058	CcSEcCtD
Dicyclomine—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000412	0.000578	CcSEcCtD
Dicyclomine—Rash—Irbesartan—type 2 diabetes mellitus	0.000409	0.000574	CcSEcCtD
Dicyclomine—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000409	0.000573	CcSEcCtD
Dicyclomine—Nausea—Metformin—type 2 diabetes mellitus	0.000408	0.000573	CcSEcCtD
Dicyclomine—Headache—Irbesartan—type 2 diabetes mellitus	0.000406	0.00057	CcSEcCtD
Dicyclomine—Dizziness—Losartan—type 2 diabetes mellitus	0.000404	0.000566	CcSEcCtD
Dicyclomine—Vomiting—Losartan—type 2 diabetes mellitus	0.000388	0.000544	CcSEcCtD
Dicyclomine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000386	0.000541	CcSEcCtD
Dicyclomine—Nausea—Irbesartan—type 2 diabetes mellitus	0.000385	0.00054	CcSEcCtD
Dicyclomine—Rash—Losartan—type 2 diabetes mellitus	0.000385	0.00054	CcSEcCtD
Dicyclomine—Dermatitis—Losartan—type 2 diabetes mellitus	0.000385	0.000539	CcSEcCtD
Dicyclomine—Headache—Losartan—type 2 diabetes mellitus	0.000382	0.000536	CcSEcCtD
Dicyclomine—Asthenia—Ramipril—type 2 diabetes mellitus	0.000376	0.000527	CcSEcCtD
Dicyclomine—Pruritus—Ramipril—type 2 diabetes mellitus	0.00037	0.000519	CcSEcCtD
Dicyclomine—Nausea—Losartan—type 2 diabetes mellitus	0.000363	0.000509	CcSEcCtD
Dicyclomine—Dizziness—Ramipril—type 2 diabetes mellitus	0.000346	0.000485	CcSEcCtD
Dicyclomine—Vomiting—Ramipril—type 2 diabetes mellitus	0.000333	0.000467	CcSEcCtD
Dicyclomine—Rash—Ramipril—type 2 diabetes mellitus	0.00033	0.000463	CcSEcCtD
Dicyclomine—Dermatitis—Ramipril—type 2 diabetes mellitus	0.00033	0.000462	CcSEcCtD
Dicyclomine—Headache—Ramipril—type 2 diabetes mellitus	0.000328	0.00046	CcSEcCtD
Dicyclomine—Nausea—Ramipril—type 2 diabetes mellitus	0.000311	0.000436	CcSEcCtD
Dicyclomine—CHRM1—Signaling Pathways—EDNRA—type 2 diabetes mellitus	5.27e-05	0.000184	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—AGT—type 2 diabetes mellitus	5.27e-05	0.000184	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—EDNRA—type 2 diabetes mellitus	5.25e-05	0.000183	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—CALM1—type 2 diabetes mellitus	5.25e-05	0.000183	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CYBA—type 2 diabetes mellitus	5.25e-05	0.000183	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—CALM1—type 2 diabetes mellitus	5.23e-05	0.000182	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CYBA—type 2 diabetes mellitus	5.23e-05	0.000182	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—EDNRA—type 2 diabetes mellitus	5.2e-05	0.000181	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—CALM1—type 2 diabetes mellitus	5.18e-05	0.00018	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CYBA—type 2 diabetes mellitus	5.18e-05	0.00018	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	5.16e-05	0.00018	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	5.15e-05	0.000179	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	5.14e-05	0.000179	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PLAT—type 2 diabetes mellitus	5.14e-05	0.000179	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—GHRL—type 2 diabetes mellitus	5.14e-05	0.000179	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—PSMD6—type 2 diabetes mellitus	5.13e-05	0.000179	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—SREBF1—type 2 diabetes mellitus	5.13e-05	0.000179	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—SNAP25—type 2 diabetes mellitus	5.13e-05	0.000179	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PLAT—type 2 diabetes mellitus	5.12e-05	0.000178	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—GHRL—type 2 diabetes mellitus	5.12e-05	0.000178	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	5.09e-05	0.000177	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CALCA—type 2 diabetes mellitus	5.07e-05	0.000177	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PLAT—type 2 diabetes mellitus	5.07e-05	0.000177	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—GHRL—type 2 diabetes mellitus	5.07e-05	0.000177	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CALCA—type 2 diabetes mellitus	5.06e-05	0.000176	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—CTGF—type 2 diabetes mellitus	5.04e-05	0.000175	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CALCA—type 2 diabetes mellitus	5.01e-05	0.000174	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—HMGCR—type 2 diabetes mellitus	4.99e-05	0.000174	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	4.93e-05	0.000172	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	4.92e-05	0.000171	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	4.92e-05	0.000171	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—ADRA2A—type 2 diabetes mellitus	4.88e-05	0.00017	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	4.87e-05	0.00017	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.83e-05	0.000168	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—GNB3—type 2 diabetes mellitus	4.83e-05	0.000168	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—HMOX1—type 2 diabetes mellitus	4.8e-05	0.000167	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	4.78e-05	0.000166	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	4.76e-05	0.000166	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	4.76e-05	0.000166	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	4.74e-05	0.000165	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—CAT—type 2 diabetes mellitus	4.74e-05	0.000165	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	4.72e-05	0.000164	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—GCG—type 2 diabetes mellitus	4.7e-05	0.000164	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	4.7e-05	0.000164	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	4.69e-05	0.000164	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—CYP2E1—type 2 diabetes mellitus	4.69e-05	0.000163	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—GCG—type 2 diabetes mellitus	4.68e-05	0.000163	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PTPN1—type 2 diabetes mellitus	4.68e-05	0.000163	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—CYP1A2—type 2 diabetes mellitus	4.64e-05	0.000162	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—SLC2A1—type 2 diabetes mellitus	4.64e-05	0.000162	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—GCG—type 2 diabetes mellitus	4.64e-05	0.000162	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PTPN1—type 2 diabetes mellitus	4.64e-05	0.000162	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	4.62e-05	0.000161	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	4.61e-05	0.00016	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	4.61e-05	0.00016	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—APOB—type 2 diabetes mellitus	4.6e-05	0.00016	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	4.59e-05	0.00016	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	4.56e-05	0.000159	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	4.55e-05	0.000158	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—CYP3A4—type 2 diabetes mellitus	4.52e-05	0.000158	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	4.5e-05	0.000157	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—GSTM1—type 2 diabetes mellitus	4.48e-05	0.000156	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—SLC2A4—type 2 diabetes mellitus	4.45e-05	0.000155	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—GCG—type 2 diabetes mellitus	4.45e-05	0.000155	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	4.4e-05	0.000153	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—LPL—type 2 diabetes mellitus	4.39e-05	0.000153	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—CCL2—type 2 diabetes mellitus	4.38e-05	0.000153	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—CCL2—type 2 diabetes mellitus	4.34e-05	0.000151	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	4.32e-05	0.00015	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	4.31e-05	0.00015	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—AKT2—type 2 diabetes mellitus	4.3e-05	0.00015	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—ADCY5—type 2 diabetes mellitus	4.3e-05	0.00015	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	4.3e-05	0.00015	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—GPX1—type 2 diabetes mellitus	4.29e-05	0.000149	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—AKT2—type 2 diabetes mellitus	4.26e-05	0.000149	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	4.26e-05	0.000148	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—CD36—type 2 diabetes mellitus	4.17e-05	0.000145	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—PPP2CA—type 2 diabetes mellitus	4.12e-05	0.000144	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	4.09e-05	0.000142	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	4.07e-05	0.000142	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—GNB3—type 2 diabetes mellitus	4.05e-05	0.000141	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—GNB3—type 2 diabetes mellitus	4.04e-05	0.000141	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	4.03e-05	0.000141	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—GNB3—type 2 diabetes mellitus	4e-05	0.000139	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—AVP—type 2 diabetes mellitus	3.99e-05	0.000139	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—MMP3—type 2 diabetes mellitus	3.99e-05	0.000139	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—MMP3—type 2 diabetes mellitus	3.98e-05	0.000139	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—AVP—type 2 diabetes mellitus	3.98e-05	0.000139	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—IGF2—type 2 diabetes mellitus	3.98e-05	0.000139	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—IGF2—type 2 diabetes mellitus	3.96e-05	0.000138	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	3.96e-05	0.000138	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—MTHFR—type 2 diabetes mellitus	3.96e-05	0.000138	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	3.95e-05	0.000137	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—AVP—type 2 diabetes mellitus	3.94e-05	0.000137	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—MMP3—type 2 diabetes mellitus	3.94e-05	0.000137	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—IGF2—type 2 diabetes mellitus	3.93e-05	0.000137	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	3.92e-05	0.000136	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	3.91e-05	0.000136	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	3.91e-05	0.000136	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—PPARA—type 2 diabetes mellitus	3.88e-05	0.000135	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	3.87e-05	0.000135	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—APOB—type 2 diabetes mellitus	3.86e-05	0.000134	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—APOB—type 2 diabetes mellitus	3.85e-05	0.000134	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	3.84e-05	0.000134	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—GNB3—type 2 diabetes mellitus	3.83e-05	0.000134	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.83e-05	0.000134	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—IGF1R—type 2 diabetes mellitus	3.83e-05	0.000134	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—HMOX1—type 2 diabetes mellitus	3.82e-05	0.000133	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—APOB—type 2 diabetes mellitus	3.81e-05	0.000133	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—EDN1—type 2 diabetes mellitus	3.8e-05	0.000132	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	3.8e-05	0.000132	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—EDN1—type 2 diabetes mellitus	3.79e-05	0.000132	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—CAT—type 2 diabetes mellitus	3.77e-05	0.000131	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—AGT—type 2 diabetes mellitus	3.76e-05	0.000131	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—EDN1—type 2 diabetes mellitus	3.75e-05	0.000131	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—CALM1—type 2 diabetes mellitus	3.7e-05	0.000129	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—LPL—type 2 diabetes mellitus	3.69e-05	0.000128	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—APOE—type 2 diabetes mellitus	3.68e-05	0.000128	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—LPL—type 2 diabetes mellitus	3.67e-05	0.000128	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—APOB—type 2 diabetes mellitus	3.66e-05	0.000127	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—APOA1—type 2 diabetes mellitus	3.64e-05	0.000127	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—LPL—type 2 diabetes mellitus	3.64e-05	0.000127	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	3.61e-05	0.000126	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—ADCY5—type 2 diabetes mellitus	3.6e-05	0.000125	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	3.56e-05	0.000124	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—GSTM1—type 2 diabetes mellitus	3.56e-05	0.000124	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—LPL—type 2 diabetes mellitus	3.49e-05	0.000122	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	3.46e-05	0.00012	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	3.45e-05	0.00012	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—ADCY5—type 2 diabetes mellitus	3.42e-05	0.000119	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	3.41e-05	0.000119	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—GPX1—type 2 diabetes mellitus	3.41e-05	0.000119	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CCR5—type 2 diabetes mellitus	3.4e-05	0.000118	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CCR5—type 2 diabetes mellitus	3.39e-05	0.000118	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CCR5—type 2 diabetes mellitus	3.35e-05	0.000117	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—C3—type 2 diabetes mellitus	3.32e-05	0.000116	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—CD36—type 2 diabetes mellitus	3.32e-05	0.000116	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—C3—type 2 diabetes mellitus	3.31e-05	0.000115	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—C3—type 2 diabetes mellitus	3.28e-05	0.000114	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—PPP2CA—type 2 diabetes mellitus	3.28e-05	0.000114	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—PPARG—type 2 diabetes mellitus	3.21e-05	0.000112	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	3.16e-05	0.00011	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—IRS2—type 2 diabetes mellitus	3.16e-05	0.00011	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—HIF1A—type 2 diabetes mellitus	3.15e-05	0.00011	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—AGT—type 2 diabetes mellitus	3.15e-05	0.00011	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—IRS2—type 2 diabetes mellitus	3.15e-05	0.00011	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—INS—type 2 diabetes mellitus	3.15e-05	0.00011	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—AGT—type 2 diabetes mellitus	3.14e-05	0.000109	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—MTHFR—type 2 diabetes mellitus	3.14e-05	0.000109	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	3.12e-05	0.000109	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—IRS2—type 2 diabetes mellitus	3.12e-05	0.000109	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—AGT—type 2 diabetes mellitus	3.11e-05	0.000108	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CALM1—type 2 diabetes mellitus	3.1e-05	0.000108	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CALM1—type 2 diabetes mellitus	3.09e-05	0.000108	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—APOE—type 2 diabetes mellitus	3.09e-05	0.000108	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—LEP—type 2 diabetes mellitus	3.09e-05	0.000108	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—PPARA—type 2 diabetes mellitus	3.08e-05	0.000107	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—LEP—type 2 diabetes mellitus	3.08e-05	0.000107	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—APOE—type 2 diabetes mellitus	3.08e-05	0.000107	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CALM1—type 2 diabetes mellitus	3.06e-05	0.000107	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—APOA1—type 2 diabetes mellitus	3.05e-05	0.000106	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—LEP—type 2 diabetes mellitus	3.05e-05	0.000106	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—APOE—type 2 diabetes mellitus	3.05e-05	0.000106	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—APOA1—type 2 diabetes mellitus	3.04e-05	0.000106	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—APOA1—type 2 diabetes mellitus	3.01e-05	0.000105	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—AGT—type 2 diabetes mellitus	2.99e-05	0.000104	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—CALM1—type 2 diabetes mellitus	2.94e-05	0.000102	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—APOE—type 2 diabetes mellitus	2.93e-05	0.000102	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.91e-05	0.000102	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.9e-05	0.000101	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—APOA1—type 2 diabetes mellitus	2.89e-05	0.000101	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—ALB—type 2 diabetes mellitus	2.88e-05	0.0001	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.88e-05	0.0001	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—PIK3R1—type 2 diabetes mellitus	2.76e-05	9.61e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—NOS3—type 2 diabetes mellitus	2.76e-05	9.61e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.76e-05	9.6e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.75e-05	9.57e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.72e-05	9.48e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—INS—type 2 diabetes mellitus	2.64e-05	9.19e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—INS—type 2 diabetes mellitus	2.63e-05	9.17e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—INS—type 2 diabetes mellitus	2.61e-05	9.08e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.6e-05	9.05e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.59e-05	9.02e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.56e-05	8.93e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.55e-05	8.89e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.55e-05	8.89e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—PPARG—type 2 diabetes mellitus	2.55e-05	8.88e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.54e-05	8.87e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.54e-05	8.86e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.54e-05	8.85e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.53e-05	8.82e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—PTGS2—type 2 diabetes mellitus	2.52e-05	8.79e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.52e-05	8.78e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.52e-05	8.77e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.51e-05	8.74e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—INS—type 2 diabetes mellitus	2.5e-05	8.71e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.42e-05	8.45e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.42e-05	8.42e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.39e-05	8.34e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.31e-05	8.06e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.31e-05	8.06e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.31e-05	8.04e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.31e-05	8.04e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—ALB—type 2 diabetes mellitus	2.29e-05	7.98e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.28e-05	7.96e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.28e-05	7.96e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.19e-05	7.64e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—NOS3—type 2 diabetes mellitus	2.19e-05	7.64e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—RELA—type 2 diabetes mellitus	2.18e-05	7.59e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—RELA—type 2 diabetes mellitus	2.17e-05	7.57e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—RELA—type 2 diabetes mellitus	2.15e-05	7.49e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—PTGS2—type 2 diabetes mellitus	2e-05	6.98e-05	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.98e-05	6.91e-05	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.98e-05	6.89e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.97e-05	6.85e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.96e-05	6.82e-05	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.96e-05	6.82e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.95e-05	6.8e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.95e-05	6.78e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.94e-05	6.76e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.93e-05	6.71e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.86e-05	6.47e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.85e-05	6.45e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.84e-05	6.4e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.83e-05	6.39e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.83e-05	6.38e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.81e-05	6.32e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.8e-05	6.27e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.8e-05	6.25e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.78e-05	6.19e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.71e-05	5.96e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—SRC—type 2 diabetes mellitus	1.71e-05	5.95e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—SRC—type 2 diabetes mellitus	1.69e-05	5.89e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.67e-05	5.81e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.66e-05	5.79e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.65e-05	5.73e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.53e-05	5.33e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.53e-05	5.31e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.51e-05	5.26e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.5e-05	5.23e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.5e-05	5.21e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.48e-05	5.16e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—AKT1—type 2 diabetes mellitus	1.27e-05	4.42e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.15e-05	4.02e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—IL6—type 2 diabetes mellitus	1.15e-05	4e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—IL6—type 2 diabetes mellitus	1.14e-05	3.97e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.06e-05	3.71e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.06e-05	3.69e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.05e-05	3.66e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—AKT1—type 2 diabetes mellitus	1.01e-05	3.51e-05	CbGpPWpGaD
